Johnson & Johnson (JNJ) Q2 earnings
Johnson & Johnson beat Wall Street estimates for second-quarter sales and profit on Wednesday, as strong growth from…
Johnson & Johnson has a chance to show it’s more than just a rotation winner
Johnson & Johnson shares have showed signs of life ahead of earnings. For the stock to keep running,…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
AstraZeneca stock dives 9% after heart drug trial misses target
Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
Employers aren’t expanding coverage of GLP-1 obesity drugs: survey
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Abivax stock soars after new data on bowel disease medicine
Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for…
Centene to offer buyouts to some employees
Sheldon Cooper | Lightrocket | Getty Images Centene said it offered buyouts to some employees on Monday, as…
Space race comes for pharma: Why drug development is heading to orbit
The highly anticipated SpaceX mega-IPO is part of a space frenzy that is moving beyond satellite connectivity, launch…
Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage
Novo Nordisk and Eli Lilly took their GLP-1 pill battle to the preeminent obesity meeting this weekend as…
World Cup 2026: Health officials focused on Ebola, measles
Signage for the FIFA World Cup at The Shops at Columbus Circle in New York, May 21, 2026.…
Eli Lilly makes a new push into vaccines – here’s what to know
The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…